Evaluation of ibuprofen use on the immune system indicators and force in disabled paralympic powerlifters of different sport levels

Detalhes bibliográficos
Autor(a) principal: Aidar, Felipe J.
Data de Publicação: 2022
Outros Autores: Fraga, Guacira S., Getirana-Mota, Márcio, Marçal, Anderson Carlos, Santos, Jymmys L., Souza, Raphael Fabricio de, Vieira-Souza, Lucio Marques, Ferreira, Alexandre Reis Pires, Matos, Dihogo Gama de, Almeida-Neto, Paulo Francisco de, Garrido, Nuno Domingos, Díaz-de-Durana, Alfonso López, Knechtle, Beat, Cabral, Breno Guilherme de Araújo Tinoco, Murawska-Ciałowicz, Eugenia, Nobari, Hadi, Silva, Ana Filipa, Clemente, Filipe Manuel, Badicu, Georgian
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/20.500.11960/3608
Resumo: Background: Paralympic powerlifting (PP) training is typically intense and causes fatigue and alterations in the immune system. Objective: To analyze whether IBU would affect performance and the immune system after training in PP. Methodology: 10 athletes at the national level (NL) and 10 at the regional level (RL) participated in the study, where force and blood indicators were evaluated after training. The study took place over three weeks: (1) familiarization and (2 and 3) comparison between recovery methods, with ibuprofen or placebo (IBU vs. PLA), 800 mg. In the evaluation of the force, the peak torque (PT), fatigue index (FI), and blood immune system biomarkers were analyzed. The training consisted of five sets of five repetitions with 80% of one maximum repetition (5 × 5, 80% 1RM) on the bench press. Results: The PT at the national level using IBU was higher than with PLA (p = 0.007, η2p = 0.347), and the FI in the NL was lower with IBU than with PLA (p = 0.002, η2p = 0.635), and when comparing the use of IBU, the NL showed less fatigue than the regional level (p = 0.004, η2p = 0.414). Leukocytes, with the use of IBU in the NL group, were greater than in the RL (p = 0.001, η2p = 0.329). Neutrophils, in the NL with IBU, were greater than in the RL with IBU and PLA (p = 0.025, η2p = 0.444). Lymphocytes, in NL with IBU were lower than in RL with IBU and PLA (p = 0.001, η2p = 0.491). Monocytes, in the NL with IBU and PLA, were lower than in the RL with IBU (p = 0.049, η2p = 0.344). For hemoglobin, hematocrit, and erythrocyte, the NL with IBU and PLA were higher than the RL with IBU and PLA (p < 0.05). Ammonia, with the use of IBU in the NL, obtained values higher than in the RL (p = 0.007), and with the use of PLA, the NL was higher than the RL (p = 0.038, η2p = 0.570). Conclusion: The training level tends to influence the immune system and, combined with the use of the IBU, it tends to improve recovery and the immune system.
id RCAP_e376774b8a808e22aa93d330d6fd9304
oai_identifier_str oai:repositorio.ipvc.pt:20.500.11960/3608
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Evaluation of ibuprofen use on the immune system indicators and force in disabled paralympic powerlifters of different sport levelsMuscle strengthIbuprofenParalympic powerliftingImmune systemRecovery of functionBackground: Paralympic powerlifting (PP) training is typically intense and causes fatigue and alterations in the immune system. Objective: To analyze whether IBU would affect performance and the immune system after training in PP. Methodology: 10 athletes at the national level (NL) and 10 at the regional level (RL) participated in the study, where force and blood indicators were evaluated after training. The study took place over three weeks: (1) familiarization and (2 and 3) comparison between recovery methods, with ibuprofen or placebo (IBU vs. PLA), 800 mg. In the evaluation of the force, the peak torque (PT), fatigue index (FI), and blood immune system biomarkers were analyzed. The training consisted of five sets of five repetitions with 80% of one maximum repetition (5 × 5, 80% 1RM) on the bench press. Results: The PT at the national level using IBU was higher than with PLA (p = 0.007, η2p = 0.347), and the FI in the NL was lower with IBU than with PLA (p = 0.002, η2p = 0.635), and when comparing the use of IBU, the NL showed less fatigue than the regional level (p = 0.004, η2p = 0.414). Leukocytes, with the use of IBU in the NL group, were greater than in the RL (p = 0.001, η2p = 0.329). Neutrophils, in the NL with IBU, were greater than in the RL with IBU and PLA (p = 0.025, η2p = 0.444). Lymphocytes, in NL with IBU were lower than in RL with IBU and PLA (p = 0.001, η2p = 0.491). Monocytes, in the NL with IBU and PLA, were lower than in the RL with IBU (p = 0.049, η2p = 0.344). For hemoglobin, hematocrit, and erythrocyte, the NL with IBU and PLA were higher than the RL with IBU and PLA (p < 0.05). Ammonia, with the use of IBU in the NL, obtained values higher than in the RL (p = 0.007), and with the use of PLA, the NL was higher than the RL (p = 0.038, η2p = 0.570). Conclusion: The training level tends to influence the immune system and, combined with the use of the IBU, it tends to improve recovery and the immune system.2023-10-31T14:27:33Z2022-07-18T00:00:00Z2022-07-182023-08-28T17:14:32Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/20.500.11960/3608eng2227-903210.3390/healthcare10071331Aidar, Felipe J.Fraga, Guacira S.Getirana-Mota, MárcioMarçal, Anderson CarlosSantos, Jymmys L.Souza, Raphael Fabricio deVieira-Souza, Lucio MarquesFerreira, Alexandre Reis PiresMatos, Dihogo Gama deAlmeida-Neto, Paulo Francisco deGarrido, Nuno DomingosDíaz-de-Durana, Alfonso LópezKnechtle, BeatCabral, Breno Guilherme de Araújo TinocoMurawska-Ciałowicz, EugeniaNobari, HadiSilva, Ana FilipaClemente, Filipe ManuelBadicu, Georgianinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-02T07:35:42Zoai:repositorio.ipvc.pt:20.500.11960/3608Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:26:29.467693Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Evaluation of ibuprofen use on the immune system indicators and force in disabled paralympic powerlifters of different sport levels
title Evaluation of ibuprofen use on the immune system indicators and force in disabled paralympic powerlifters of different sport levels
spellingShingle Evaluation of ibuprofen use on the immune system indicators and force in disabled paralympic powerlifters of different sport levels
Aidar, Felipe J.
Muscle strength
Ibuprofen
Paralympic powerlifting
Immune system
Recovery of function
title_short Evaluation of ibuprofen use on the immune system indicators and force in disabled paralympic powerlifters of different sport levels
title_full Evaluation of ibuprofen use on the immune system indicators and force in disabled paralympic powerlifters of different sport levels
title_fullStr Evaluation of ibuprofen use on the immune system indicators and force in disabled paralympic powerlifters of different sport levels
title_full_unstemmed Evaluation of ibuprofen use on the immune system indicators and force in disabled paralympic powerlifters of different sport levels
title_sort Evaluation of ibuprofen use on the immune system indicators and force in disabled paralympic powerlifters of different sport levels
author Aidar, Felipe J.
author_facet Aidar, Felipe J.
Fraga, Guacira S.
Getirana-Mota, Márcio
Marçal, Anderson Carlos
Santos, Jymmys L.
Souza, Raphael Fabricio de
Vieira-Souza, Lucio Marques
Ferreira, Alexandre Reis Pires
Matos, Dihogo Gama de
Almeida-Neto, Paulo Francisco de
Garrido, Nuno Domingos
Díaz-de-Durana, Alfonso López
Knechtle, Beat
Cabral, Breno Guilherme de Araújo Tinoco
Murawska-Ciałowicz, Eugenia
Nobari, Hadi
Silva, Ana Filipa
Clemente, Filipe Manuel
Badicu, Georgian
author_role author
author2 Fraga, Guacira S.
Getirana-Mota, Márcio
Marçal, Anderson Carlos
Santos, Jymmys L.
Souza, Raphael Fabricio de
Vieira-Souza, Lucio Marques
Ferreira, Alexandre Reis Pires
Matos, Dihogo Gama de
Almeida-Neto, Paulo Francisco de
Garrido, Nuno Domingos
Díaz-de-Durana, Alfonso López
Knechtle, Beat
Cabral, Breno Guilherme de Araújo Tinoco
Murawska-Ciałowicz, Eugenia
Nobari, Hadi
Silva, Ana Filipa
Clemente, Filipe Manuel
Badicu, Georgian
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Aidar, Felipe J.
Fraga, Guacira S.
Getirana-Mota, Márcio
Marçal, Anderson Carlos
Santos, Jymmys L.
Souza, Raphael Fabricio de
Vieira-Souza, Lucio Marques
Ferreira, Alexandre Reis Pires
Matos, Dihogo Gama de
Almeida-Neto, Paulo Francisco de
Garrido, Nuno Domingos
Díaz-de-Durana, Alfonso López
Knechtle, Beat
Cabral, Breno Guilherme de Araújo Tinoco
Murawska-Ciałowicz, Eugenia
Nobari, Hadi
Silva, Ana Filipa
Clemente, Filipe Manuel
Badicu, Georgian
dc.subject.por.fl_str_mv Muscle strength
Ibuprofen
Paralympic powerlifting
Immune system
Recovery of function
topic Muscle strength
Ibuprofen
Paralympic powerlifting
Immune system
Recovery of function
description Background: Paralympic powerlifting (PP) training is typically intense and causes fatigue and alterations in the immune system. Objective: To analyze whether IBU would affect performance and the immune system after training in PP. Methodology: 10 athletes at the national level (NL) and 10 at the regional level (RL) participated in the study, where force and blood indicators were evaluated after training. The study took place over three weeks: (1) familiarization and (2 and 3) comparison between recovery methods, with ibuprofen or placebo (IBU vs. PLA), 800 mg. In the evaluation of the force, the peak torque (PT), fatigue index (FI), and blood immune system biomarkers were analyzed. The training consisted of five sets of five repetitions with 80% of one maximum repetition (5 × 5, 80% 1RM) on the bench press. Results: The PT at the national level using IBU was higher than with PLA (p = 0.007, η2p = 0.347), and the FI in the NL was lower with IBU than with PLA (p = 0.002, η2p = 0.635), and when comparing the use of IBU, the NL showed less fatigue than the regional level (p = 0.004, η2p = 0.414). Leukocytes, with the use of IBU in the NL group, were greater than in the RL (p = 0.001, η2p = 0.329). Neutrophils, in the NL with IBU, were greater than in the RL with IBU and PLA (p = 0.025, η2p = 0.444). Lymphocytes, in NL with IBU were lower than in RL with IBU and PLA (p = 0.001, η2p = 0.491). Monocytes, in the NL with IBU and PLA, were lower than in the RL with IBU (p = 0.049, η2p = 0.344). For hemoglobin, hematocrit, and erythrocyte, the NL with IBU and PLA were higher than the RL with IBU and PLA (p < 0.05). Ammonia, with the use of IBU in the NL, obtained values higher than in the RL (p = 0.007), and with the use of PLA, the NL was higher than the RL (p = 0.038, η2p = 0.570). Conclusion: The training level tends to influence the immune system and, combined with the use of the IBU, it tends to improve recovery and the immune system.
publishDate 2022
dc.date.none.fl_str_mv 2022-07-18T00:00:00Z
2022-07-18
2023-10-31T14:27:33Z
2023-08-28T17:14:32Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/20.500.11960/3608
url http://hdl.handle.net/20.500.11960/3608
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2227-9032
10.3390/healthcare10071331
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134146188017664